TELA Bio, Inc.
TELA
$1.27
-$0.03-2.31%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 21.25% | -98.98% | 28.56% | 5.34% | -16.77% |
| Total Depreciation and Amortization | 8.43% | 14.10% | 65.22% | 20.64% | 16.36% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -11.70% | 131.97% | 37.94% | 3.67% | 0.32% |
| Change in Net Operating Assets | 307.78% | 81.72% | -866.97% | -137.34% | 104.01% |
| Cash from Operations | 26.10% | 32.39% | 31.85% | -28.92% | 5.03% |
| Capital Expenditure | 61.87% | 89.47% | -28.78% | 8.96% | -90.45% |
| Sale of Property, Plant, and Equipment | -- | -- | 45,233.33% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -13.11% | -96.60% | -- | -- | -- |
| Cash from Investing | 204.48% | -97.06% | 1.55% | 8.96% | 142.68% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -84.11% | 164,973.08% | 53.95% | -99.99% |
| Repurchase of Common Stock | 72.73% | 46.04% | -175.00% | -280.00% | -1,000.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 40.00% | -307.14% | 194,936.36% | 38.03% | -100.01% |
| Foreign Exchange rate Adjustments | -1,166.67% | -391.30% | 1,200.00% | -469.70% | -107.79% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 26.21% | -2.62% | 415.57% | -30.17% | -130.30% |